Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(4)
Published: Nov. 21, 2023
Abstract
Hypoxia,
a
prominent
hallmark
of
hepatocellular
carcinoma
(HCC),
undermines
curative
outcomes,
elevates
recurrence
rates,
and
fosters
metastasis,
particularly
during
photodynamic
therapy
(PDT)
in
clinical
settings.
Studies
indicate
that
alleviating
tumor
hypoxia
enhances
PDT
efficacy.
However,
persistent
challenges,
including
suboptimal
oxygen
delivery
efficiency
absence
real‐time
feedback
on
blood
fluctuations
PDT,
considerably
impede
therapeutic
efficacy
treatment.
This
study
addresses
these
issues
using
near‐infrared‐II
(NIR‐II)
photoacoustic
(PA)
imaging
for
tumor‐targeted
controlled
release.
For
this
purpose,
biomimetic
system
designated
BLICP@O
2
is
developed,
which
utilizes
hybrid
cell
membranes
thermosensitive
liposomes
as
carriers,
incorporating
the
NIR‐II
dye
IR1048,
photosensitizer
chlorin
e6
(Ce6),
perfluorohexane.
Upon
sequential
irradiation
at
1064
690
nm,
exhibits
significant
photothermal
effects.
Photothermal
heating
triggers
release,
enhancing
effect
Ce6.
Blood
changes
are
tracked
by
multispectral
PA
imaging.
Enhanced
efficacy,
mediated
relief,
convincingly
demonstrated
both
vitro
vivo.
work
presents
an
imaging‐guided,
dual‐wavelength
programmed
cascaded
treatment
strategy
with
monitoring
imaging,
offering
valuable
insights
overcoming
challenges
PDT‐based
cancer
therapy.
Small Science,
Journal Year:
2022,
Volume and Issue:
2(6)
Published: May 8, 2022
Carbon
dots
(CDs),
comprising
crystalline
graphitized
carbon
cores
and
polymer
surface
groups,
are
currently
attracting
a
lot
of
interest
in
biological
fields
owing
to
their
fluorescent
properties,
high
photostability,
biocompatibility
low
toxicity.
In
addition,
the
easy
preparation
functionalization
CDs
stimulate
development
CDs‐based
composite
materials
with
specific
functions.
Presently,
applications
growing
at
remarkable
speed,
justifying
need
for
up‐to‐date
review
articles
that
capture
recent
progress
this
blossoming
field.
review,
breakthroughs
synthesis,
modification,
optical
toxicology
biocatalytic
platforms
described.
Further,
research
related
bioimaging,
biosensing,
drug
delivery,
antibacterial,
anticancer
(photothermal
therapy,
photodynamic
therapy
synergistic
therapy)
antiviral
therapies
involving
discussed
detail.
Finally,
perspective
on
prospects
challenges
biomedicine
biotechnology
is
provided.
Journal of the American Chemical Society,
Journal Year:
2023,
Volume and Issue:
145(7), P. 4081 - 4087
Published: Feb. 13, 2023
The
highly
oxygen-dependent
nature
of
photodynamic
therapy
(PDT)
limits
its
therapeutic
efficacy
against
hypoxic
solid
tumors
in
clinics,
which
is
an
urgent
problem
to
be
solved.
Herein,
we
develop
oxygen-independent
supramolecular
agent
that
produces
hydroxyl
radical
(•OH)
by
oxidizing
water
the
presence
intracellularly
abundant
pyruvic
acid
under
oxygen-free
conditions.
A
fluorene-substituted
BODIPY
was
designed
as
electron
donor
and
coassembled
with
perylene
diimide
acceptor
form
quadruple
hydrogen-bonded
agent.
Detailed
mechanism
studies
reveal
intermolecular
transfer
charge
separation
upon
light
irradiation
result
efficient
generation
ion
pairs.
Under
conditions,
cationic
radicals
directly
oxidize
generate
cytotoxic
•OH,
anionic
electrons
acid,
realizing
catalytic
cycle.
Thus,
this
exhibited
superb
photocytotoxicity
even
severe
environments
excellent
vivo
antitumor
on
HeLa-bearing
mouse
models.
This
work
provides
a
strategy
for
constructing
agents,
opens
up
avenue
effective
PDT
tumors.
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
35(19)
Published: Sept. 19, 2022
Abstract
As
an
essential
micronutrient,
manganese
(Mn)
participates
in
various
physiological
processes
and
plays
important
roles
host
immune
system,
hematopoiesis,
endocrine
function,
oxidative
stress
regulation.
Mn‐based
nanoparticles
are
considered
to
be
biocompatible
show
versatile
applications
nanomedicine,
particular
utilized
tumor
immunotherapy
the
following
ways:
1)
acting
as
a
nanocarrier
deliver
immunotherapeutic
agents
for
immunotherapy;
2)
serving
adjuvant
regulate
microenvironment
enhance
3)
activating
host's
system
through
cGAS‐STING
pathway
trigger
4)
real‐time
monitoring
effect
by
magnetic
resonance
imaging
(MRI)
since
Mn
2+
ions
ideal
MRI
contrast
agent
which
can
significantly
T
1
‐weighted
signal
after
binding
proteins.
This
comprehensive
review
focuses
on
most
recent
progress
of
nanoplatforms
immunotherapy.
The
characteristics
first
discussed
guide
design
multifunctional
nanoplatforms.
Then
biomedical
nanoplatforms,
including
alone,
immunotherapy‐involved
multimodal
synergistic
therapy,
imaging‐guided
detail.
Finally,
challenges
future
developments
highlighted.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
16(6), P. 9304 - 9316
Published: June 14, 2022
Ultrasound
(US)-triggered
sonodynamic
therapy
(SDT)
based
on
semiconductor
nanomaterials
has
attracted
considerable
attention
for
cancer
therapy.
However,
most
inorganic
sonosensitizers
suffer
from
low
efficiency
due
to
the
rapid
recombination
of
electron-hole
pairs.
Herein,
Cu2-xO-BaTiO3
piezoelectric
heterostructure
was
fabricated
as
a
sonosensitizer
and
chemodynamic
agent,
simultaneously,
improving
reactive
oxygen
species
(ROS)
generation
therapeutic
outcome.
Under
US
irradiation,
heterojunction
with
piezotronic
effect
exhibits
high-performance
singlet
(1O2)
hydroxyl
radical
(•OH)
enhance
SDT.
Moreover,
it
possesses
Fenton-like
reaction
activity
convert
endogenous
H2O2
into
•OH
(CDT).
The
integration
SDT
CDT
substantially
boosts
ROS
cellular
mitochondria
damage,
in
vitro
vivo
results
demonstrate
high
cytotoxicity
tumor
inhibition
murine
refractory
breast
cancer.
This
work
realizes
improvement
using
heterostructures
effects.
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
35(18)
Published: Nov. 18, 2022
Abstract
The
use
of
boron
dipyrromethene
(BODIPY)
in
biomedicine
is
reviewed.
To
open,
its
synthesis
and
regulatory
strategies
are
summarized,
inspiring
cutting‐edge
work
post‐functionalization
highlighted.
A
brief
overview
assembly
model
BODIPY
then
provided:
introduced
as
a
promising
building
block
for
the
formation
single‐
multicomponent
self‐assembled
systems,
including
nanostructures
suitable
aqueous
environments,
thereby
showing
great
development
potential
supramolecular
applications.
frontier
progress
biomedical
application
thereafter
described,
supported
by
examples
frontiers
applications
BODIPY‐containing
smart
materials:
it
mainly
involves
materials
based
on
blocks
their
assemblies
fluorescence
bioimaging,
photoacoustic
imaging,
disease
treatment
photodynamic
therapy,
photothermal
immunotherapy.
Lastly,
not
only
current
status
family
field
but
also
challenges
worth
considering
summarized.
At
same
time,
insights
into
future
prospects
biomedically
applicable
provided.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Oct. 19, 2022
Abstract
Given
that
Type-I
photosensitizers
(PSs)
have
hypoxia
tolerance,
developing
general
approaches
to
prepare
PSs
is
of
great
importance,
but
remains
a
challenge.
Here,
we
report
supramolecular
strategy
for
the
preparation
photodynamic
agents,
which
simultaneously
generate
strong
oxidizing
cationic
radicals
and
superoxide
radicals,
by
introducing
electron
acceptors
existing
Type-II
PSs.
As
proof-of-concept,
three
were
designed
co-assembled
with
classical
PS
produce
quadruple
hydrogen-bonded
agents.
The
photo-induced
transfer
from
adjacent
acceptor
occurs
efficiently,
leading
generation
+•
an
anionic
radical
acceptor,
further
transfers
oxygen
form
O
2
−•
.
In
addition,
these
agents
induce
direct
photocatalytic
oxidation
NADH
turnover
frequency
as
high
53.7
min
−1
,
offers
oxygen-independent
mechanism
damage
tumors.
Accounts of Chemical Research,
Journal Year:
2022,
Volume and Issue:
55(22), P. 3253 - 3264
Published: Nov. 2, 2022
ConspectusThe
advent
of
photochemical
techniques
has
revolutionized
the
landscape
biology
and
medical
sciences.
Especially
appealing
in
this
context
is
photodynamic
therapy
(PDT),
which
a
photon-initiated
treatment
modality
that
uses
cytotoxic
reactive
oxygen
species
(ROS)
to
kill
malignant
cells.
In
past
decade,
PDT
risen
forefront
cancer
therapy.
Its
optical
control
enables
noninvasive
spatiotemporal
manipulation
process,
its
photoactive
nature
allows
unique
patterns
avoid
drug
resistance
conventional
chemotherapeutics.
However,
despite
impressive
advances
field,
achieving
widespread
clinical
adoption
remains
difficult.
A
major
concern
hostile
tumor
microenvironment,
cells
are
hypoxic,
hinders
ROS
generation
during
action.
To
overcome
"Achilles'
heel",
current
strategies
focus
primarily
on
improvement
intratumoral
O2
perfusion,
while
trials
suggest
enrichment
may
promote
cell
proliferation
metastasis,
thereby
making
FDA
approval
transformation
these
paradigms
challenging.In
an
effort
improve
hypoxia
(hPDT)
clinic,
we
have
explored
"low
no
O2-dependent"
approaches
over
years
combat
hypoxia-induced
resistance.
Account,
present
our
contributions
theme
5
years,
beginning
with
low
O2-dependent
(e.g.,
type
I
superoxide
radical
(O2•–)
generator,
O2-economizer,
mitochondrial
respiration
inhibition,
cellular
self-protective
pathway
modulation,
etc.)
progressing
O2-independent
autoadaptive
PDT/PTT
complementary
therapy,
artificial
photoredox
catalysis
cells).
These
studies
attracted
tremendous
attention.
Particularly
pioneering
work
2018,
presented
first
demonstration
O2•–-mediated
partial
O2-recyclability
mechanism
can
(
J.
Am.
Chem.
Soc.
140,
14851−14859).
This
launched
era
renewed
interest
PDT,
resulting
plethora
new
O2•–
photogenerators
developed
by
many
groups
around
world.
Moreover,
discovery
reactions
living
cells,
emerged
as
field
connecting
photochemistry
biomedicine,
stimulating
development
next-generation
phototherapeutic
tools
2022,
144,
163−173).
Our
recent
also
disclosed
"photoredox
cells"
might
be
general
action
Proc.
Natl.
Acad.
Sci.
U.S.A.
119,
e2210504119).
emergent
concepts,
molecular
designs,
mechanisms,
applications
diagnosis
therapeutics,
well
pros
cons,
discussed
depth
Account.
It
expected
date
will
use
researchers
inspire
future
efforts
identify
more
promising
hPDT
better
meet
needs
Angewandte Chemie International Edition,
Journal Year:
2022,
Volume and Issue:
61(44)
Published: Sept. 9, 2022
Abstract
Owing
to
the
high
depth
of
tissue
penetration,
non‐invasiveness,
and
controllability,
ultrasound
(US)‐mediated
sonodynamic
therapy
(SDT)
has
shown
broad
application
prospects
for
tumor
treatment.
However,
electron‐hole
separation
inefficiency
sonosensitizers
hypoxia
remain
two
major
challenges
limiting
effect
SDT.
Here,
ultrafine
photoetched
bismuth
vanadate
(BiVO
4
)
nanorods
modified
with
DSPE‐PEG
2000
(PEBVO@PEG
NRs)
were
fabricated
achieve
in
situ
self‐supply
oxygen
(O
2
reactive
species
(ROS)
hypoxic
therapy.
The
photoetching
approach
could
enhance
charge
by
inducing
enriched
vacancies
on
surface
BiVO
,
thereby
improving
generation
efficiency
ROS
O
.
PEBVO@PEG
overcome
main
obstacles
traditional
SDT
process
show
promising
therapeutic
effects,
thus
providing
new
strategies
performance
sonosensitizer
elimination.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
16(9), P. 13513 - 13553
Published: Sept. 1, 2022
Prodrugs
are
chemically
modified
drug
molecules
that
inactive
before
administration.
After
administration,
they
converted
in
situ
to
parent
drugs
and
induce
the
mechanism
of
action.
The
development
prodrugs
has
upgraded
conventional
treatments
terms
bioavailability,
targeting,
reduced
side
effects.
Especially
cancer
therapy,
application
achieved
substantial
therapeutic
From
serendipitous
discovery
early
stage
functional
design
with
pertinence
nowadays,
importance
is
self-evident.
At
present,
studying
stimuli-responsive
activation
mechanisms,
regulating
stimuli
intensity
vivo,
designing
nanoscale
prodrug
formulations
major
strategies
promote
prodrugs.
In
this
review,
we
provide
an
outlook
recent
cutting-edge
studies
on
nanosystems
from
these
three
aspects.
We
also
discuss
prospects
challenges
future
such
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(24)
Published: April 26, 2023
Photodynamic
therapy
(PDT),
with
its
advantages
of
high
targeting,
minimally
invasive,
and
low
toxicity
side
effects,
has
been
widely
used
in
the
clinical
various
tumors,
especially
superficial
tumors.
However,
tumor
microenvironment
(TME)
presents
hypoxia
due
to
oxygen
(O2
)
supply
caused
by
abnormal
vascularization
neoplastic
tissues
O2
consumption
induced
rapid
proliferation
cells.
The
efficacy
oxygen-consumping
PDT
can
be
hampered
a
hypoxic
TME.
To
address
this
problem,
researchers
have
developing
advanced
nanoplatforms
strategies
enhance
therapeutic
effect
treatment.
This
review
summarizes
recent
against
TME,
thus
enhancing
efficacy,
including
increasing
content
TME
through
delivering
tumors
situ
generations
;
decreasing
during
design
type
I
photosensitizers.
Moreover,
synergistically
combined
other
methods
such
as
chemotherapy,
photothermal
therapy,
immunotherapy,
gas
is
accounted
for
addressing
challenging
problems
mono
environments,
resistance,
proliferation,
metastasis.
Finally,
perspectives
opportunities
challenges
future
research
translations
are
provided.